|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.70 EGP | +19.99% |
|
+43.61% | +66.06% |
| 05-17 | GlaxoSmithKline Q1 consol net profit EGP 4.7 million | RE |
| 03-12 | GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +19.99% | +43.61% | +47.17% | +65.65% | +66.06% | +155.31% | +242.29% | +202.61% | +1,129.07% | 175M | |
| +1.08% | -3.93% | +4.16% | +29.33% | +8.79% | +48.03% | +160.13% | +402.96% | +1,357.45% | 1,043B | |
| +1.19% | -3.52% | +6.29% | +6.58% | +20.79% | +51.70% | +56.36% | +48.70% | +103.23% | 602B | |
| +4.21% | +1.79% | +14.35% | +21.72% | +11.34% | +33.48% | +87.04% | +116.50% | +301.75% | 449B | |
| +0.30% | -0.86% | +1.80% | +4.28% | +1.68% | +29.84% | +24.42% | -6.51% | +31.79% | 327B | |
| +0.70% | +0.10% | +2.81% | +4.70% | +13.50% | +33.28% | +46.49% | +49.74% | +54.63% | 279B | |
| -0.36% | -1.75% | -6.40% | -16.59% | -8.56% | +22.28% | +23.63% | +51.80% | +178.55% | 264B | |
| +3.70% | +2.19% | +6.82% | +6.35% | +13.53% | +24.27% | +63.38% | +49.85% | +127.57% | 201B | |
| +3.49% | +1.08% | +7.13% | -1.62% | +11.05% | +24.08% | +76.58% | +98.60% | +57.26% | 169B | |
| +1.29% | +3.67% | -3.46% | -7.64% | +0.96% | +2.15% | -30.78% | -37.70% | -31.63% | 143B | |
| +1.88% | -2.11% | +7.25% | +11.56% | +7.21% | +3.51% | +37.79% | +140.28% | +438.78% | 123B | |
| +3.05% | +4.44% | +8.21% | +2.63% | +12.18% | +28.28% | -2.31% | -10.09% | -20.38% | 124B | |
| +0.68% | +1.59% | +3.42% | -5.58% | -6.38% | -7.30% | -17.76% | -10.75% | +3.02% | 106B | |
| +0.78% | +0.56% | 0.00% | -8.00% | +8.11% | +39.60% | +49.59% | +11.60% | -4.48% | 105B | |
| +1.16% | -0.87% | -4.25% | -12.26% | -11.14% | +5.85% | +87.44% | +76.55% | +473.76% | 73.36B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -2.63% | +0.68% | +18.25% | -2.58% | -6.01% | -2.15% | +17.82% | -6.84% | +249.38% | 54.49B | |
| -1.50% | -6.19% | +24.59% | +14.40% | +27.05% | +68.11% | -6.37% | -4.81% | -49.39% | 53.63B | |
| +2.53% | +2.26% | +10.98% | -1.90% | +13.34% | +24.21% | +27.74% | +46.56% | +22.76% | 51.98B | |
| +1.15% | +3.54% | +11.95% | +4.46% | -0.05% | +4.40% | +18.28% | - | - | 43.95B | |
| Average | +1.99% | +1.83% | +8.48% | +6.08% | +9.65% | +31.00% | +50.62% | +67.72% | +245.73% | 213.79B | |
| Weighted average by Cap. | +1.46% | -1.45% | +5.15% | +10.14% | +8.81% | +33.99% | +72.52% | +137.25% | +435.45% |
- Stock Market
- Stocks
- BIOC Stock
- Sector GlaxoSmithKline S.A.E
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
